SSWM
PRPH

Sheets Smith Wealth Management’s ProPhase Labs PRPH Stock Holding History

Sheets Smith Wealth Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,830
Closed -$84.2K – 404
2025
Q1 		$84.2K Hold
20,830
– – 0.01% 349
2024
Q4 		$158K Buy
+20,830
New +$292K 0.02% 370

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sheets Smith Wealth Management's PRPH Position: Q2 2025 in Review

Sheets Smith Wealth Management sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 20,830 shares — an estimated $84.2K sold.

Sheets Smith Wealth Management first reported a position in PRPH in Q4 2024 and held it in 2 quarters. The position peaked at $158K in Q4 2024. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Sheets Smith Wealth Management reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 20,830 ProPhase Labs shares in Q2 2025, an estimated $84.2K.
  • Sheets Smith Wealth Management first reported a position in ProPhase Labs in Q4 2024 and held it in 2 quarters.
  • Sheets Smith Wealth Management's ProPhase Labs position peaked at $158K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2025, filed 15 Jul 2025.